Zobrazeno 1 - 10
of 263
pro vyhledávání: '"Farhad Jadidi Niaragh"'
Autor:
Reza Mosaddeghi Heris, Milad Shirvaliloo, Sanaz Abbaspour-Aghdam, Ali Hazrati, Ali Shariati, Hamed Rahmani Youshanlouei, Farhad Jadidi Niaragh, Hamed Valizadeh, Majid Ahmadi
Publikováno v:
Stem Cell Research & Therapy, Vol 13, Iss 1, Pp 1-14 (2022)
Abstract Parkinson's disease (PD) is the second most predominant neurodegenerative disease worldwide. It is recognized clinically by severe complications in motor function caused by progressive degeneration of dopaminergic neurons (DAn) and dopamine
Externí odkaz:
https://doaj.org/article/8ae4450a41d045faa362a9ed30419dcc
Autor:
Parisa Lotfinejad, Tohid Kazemi, Sahar Safaei, Mohammad Amini, Elmira Roshani asl, Elham Baghbani, Siamak Sandoghchian Shotorbani, Farhad Jadidi Niaragh, Afshin Derakhshani, Mahdi Abdoli Shadbad, Nicola Silvestris, Behzad Baradaran
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 138, Iss , Pp 111436- (2021)
Triple-negative breast cancer (TNBC) is an invasive tumor with a high incidence of distant metastasis and poor prognosis. In TNBC cells, high PD-L1 expression can induce an immunosuppressive tumor microenvironment, repressing the anti-tumoral immune
Externí odkaz:
https://doaj.org/article/47d308f0ac074c89a9e99ed5fc7db9c2
Autor:
Parisa Lotfinejad, Mohammad Asghari Jafarabadi, Mahdi Abdoli Shadbad, Tohid Kazemi, Fariba Pashazadeh, Siamak Sandoghchian Shotorbani, Farhad Jadidi Niaragh, Amir Baghbanzadeh, Nafiseh Vahed, Nicola Silvestris, Behzad Baradaran
Publikováno v:
Diagnostics, Vol 10, Iss 9, p 704 (2020)
This meta-analysis aimed to evaluate the prognostic value of tumor-infiltrating lymphocytes (TILs) and programmed death-ligand 1 (PD-L1), their associations with the clinicopathological characteristics, and the association between their levels in pat
Externí odkaz:
https://doaj.org/article/2dc4ca6fec704a6e9fe2610b1a6a36a3
Autor:
Mohammad Sadeghi, Asma Moslehi, Hadiseh Kheiry, Fariba Karoon Kiani, Asieh Zarei, Atefeh Khodakarami, Vahid Karpisheh, Ali Masjedi, Badrossadat Rahnama, Mohammad Hojjat-Farsangi, Mortaza Raeisi, Mehdi Yousefi, Ali Akbar Movasaghpour Akbari, Farhad Jadidi-Niaragh
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Acute myeloid leukemia (AML), a malignancy Often resistant to common chemotherapy regimens (Cytarabine (Ara-c) + Daunorubicin (DNR)), is accompanied by frequent relapses. Many factors are involved in causing chemoresistance. Heme
Externí odkaz:
https://doaj.org/article/bef54dacc09d4d8ba2dd2c68b4fcd773
Autor:
Mohammad Bakhshivand, Javad Masoumi, Farid Ghorbaninezhad, Leili Aghebati-Maleki, Dariush Shanebandi, Siamak Sandoghchian Shotorbani, Farhad Jadidi-Niaragh, Amir Baghbanzadeh, Nima Hemmat, Elham Baghbani, Amir Ghaffari, Behzad Baradaran
Publikováno v:
Heliyon, Vol 10, Iss 18, Pp e37699- (2024)
Anticancer immunotherapies with a dendritic Cell (DC) basis are becoming more popular. However, it has been suggested that the tumor's immunosuppressive mechanisms, such as inhibitory immunological checkpoint molecules, reduce the effectiveness of an
Externí odkaz:
https://doaj.org/article/b414070d87214654a63f7a613297bc16
Autor:
Ghazal Mahmoudi, Yahya Ehteshaminia, Parviz Kokhaei, Seyedeh Farzaneh Jalali, Farhad Jadidi-Niaragh, Abdol Sattar Pagheh, Seyed Ehsan Enderami, Saeid Abedian Kenari, Hadi Hassannia
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background Breast cancer remains a primary global health concern due to its limited treatment options, frequent disease recurrence, and high rates of morbidity and mortality. Thereby, there is a need for more effective treatment approaches.
Externí odkaz:
https://doaj.org/article/20b7cf74a2c146e2a0f104cf16142cb0
Autor:
Asal Barshidi, Keivan Ardeshiri, Farbod Ebrahimi, Fatemeh Alian, Ali Akbar Shekarchi, Mohammad Hojjat-Farsangi, Farhad Jadidi-Niaragh
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract The immune responses to cancer cells involve both innate and acquired immune cells. In the meantime, the most attention has been drawn to the adaptive immune cells, especially T cells, while, it is now well known that the innate immune cells
Externí odkaz:
https://doaj.org/article/00fa12b0f3804abf8c75e0fdd83fd2d5
Autor:
Atefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer, Armin Mahmoudsalehi Kheshti, Bentolhoda Rashidi, Vahid Karpisheh, Ali Masjedi, Shiva Abolhasani, Sepideh Izadi, Rafieh Bagherifar, Seyyed Sina Hejazian, Hamed Mohammadi, AliAkbar Movassaghpour, Abbas Ali Hosseinpour Feizi, Mohammad Hojjat-Farsangi, Farhad Jadidi-Niaragh
Publikováno v:
Cell Communication and Signaling, Vol 21, Iss 1, Pp 1-16 (2023)
Abstract Background Targeting influential factors in resistance to chemotherapy is one way to increase the effectiveness of chemotherapeutics. The nuclear factor erythroid 2-related factor 2 (Nrf2) pathway overexpresses in chronic lymphocytic leukemi
Externí odkaz:
https://doaj.org/article/84bb4d6d12e846eaad43995f13b52c41
Autor:
Zahra Kalaei, Reyhaneh Manafi-Farid, Bentolhoda Rashidi, Fariba Karoon Kiani, Asieh Zarei, Mehrdad Fathi, Farhad Jadidi-Niaragh
Publikováno v:
Cell Communication and Signaling, Vol 21, Iss 1, Pp 1-17 (2023)
Abstract The identification of contributing factors leading to the development of Colorectal Cancer (CRC), as the third fatal malignancy, is crucial. Today, the tumor microenvironment has been shown to play a key role in CRC progression. Fibroblast-A
Externí odkaz:
https://doaj.org/article/e64331819a174e828bddef2f87af08c5
Autor:
Hossein Ranjbaran, Yahya Ehteshaminia, Mohammadreza Nadernezhad, Seyedeh Farzaneh Jalali, Farhad Jadidi-Niaragh, Abdol Sattar Pagheh, Seyed Ehsan Enderami, Saeid Abedian Kenari, Hadi Hassannia
Publikováno v:
Heliyon, Vol 10, Iss 1, Pp e23478- (2024)
The use of passive immunotherapy, either as plasma or purified antibodies, has been recommended to treat the emerging infectious diseases (EIDs) in the absence of alternative therapeutic options. Here, we compare the neutralization potency of various
Externí odkaz:
https://doaj.org/article/16bbee89e4364b52a3e2bf8e5eb111ed